Sabine Grimm - Publications

Affiliations: 
Psychology Leipzig University, Leipzig, Sachsen, Germany 

58/102 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Coy N, Bendixen A, Grimm S, Roeber U, Schröger E. Conditional deviant repetition in the oddball paradigm modulates processing at the level of P3a but not MMN. Psychophysiology. e14545. PMID 38366704 DOI: 10.1111/psyp.14545  0.818
2023 Feder S, Miksch J, Grimm S, Krems JF, Bendixen A. Using event-related brain potentials to evaluate motor-auditory latencies in virtual reality. Frontiers in Neuroergonomics. 4: 1196507. PMID 38234486 DOI: 10.3389/fnrgo.2023.1196507  0.353
2023 Ringer H, Schröger E, Grimm S. Neural signatures of automatic repetition detection in temporally regular and jittered acoustic sequences. Plos One. 18: e0284836. PMID 37948467 DOI: 10.1371/journal.pone.0284836  0.793
2023 Ringer H, Rösch SA, Roeber U, Deller J, Escera C, Grimm S. That sounds awful! Does sound unpleasantness modulate the mismatch negativity and its habituation? Psychophysiology. e14450. PMID 37779371 DOI: 10.1111/psyp.14450  0.785
2023 Coy N, Bendixen A, Grimm S, Roeber U, Schröger E. Deviants violating higher-order auditory regularities can become predictive and facilitate behaviour. Attention, Perception & Psychophysics. PMID 37532882 DOI: 10.3758/s13414-023-02763-9  0.798
2023 Ringer H, Schröger E, Grimm S. Perceptual learning of random acoustic patterns: Impact of temporal regularity and attention. The European Journal of Neuroscience. PMID 37095717 DOI: 10.1111/ejn.15996  0.768
2023 Weise A, Grimm S, Maria Rimmele J, Schröger E. Auditory representations for long lasting sounds: Insights from event-related brain potentials and neural oscillations. Brain and Language. 237: 105221. PMID 36623340 DOI: 10.1016/j.bandl.2022.105221  0.799
2022 Ringer H, Schröger E, Grimm S. Within- and between-subject consistency of perceptual segmentation in periodic noise: A combined behavioral tapping and EEG study. Psychophysiology. e14174. PMID 36106761 DOI: 10.1111/psyp.14174  0.731
2021 Bader M, Schröger E, Grimm S. Auditory Pattern Representations Under Conditions of Uncertainty-An ERP Study. Frontiers in Human Neuroscience. 15: 682820. PMID 34305553 DOI: 10.3389/fnhum.2021.682820  0.815
2021 Coy N, Bader M, Schröger E, Grimm S. Change detection of auditory tonal patterns defined by absolute versus relative pitch information. A combined behavioural and EEG study. Plos One. 16: e0247495. PMID 33630974 DOI: 10.1371/journal.pone.0247495  0.834
2021 Hodapp A, Grimm S. Neural signatures of temporal regularity and recurring patterns in random tonal sound sequences. The European Journal of Neuroscience. 53: 2740-2754. PMID 33481296 DOI: 10.1111/ejn.15123  0.832
2018 Cacciaglia R, Costa-Faidella J, Zarnowiec K, Grimm S, Escera C. Auditory predictions shape the neural responses to stimulus repetition and sensory change. Neuroimage. 186: 200-210. PMID 30414982 DOI: 10.1016/J.Neuroimage.2018.11.007  0.57
2018 Aghamolaei M, Jafari Z, Grimm S, Zarnowiec K, Najafi-Koopaie M, Escera C. The effects of aging on early stages of the auditory deviance detection system. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 129: 2252-2258. PMID 30216909 DOI: 10.1016/J.Clinph.2018.08.006  0.414
2017 Gandras K, Grimm S, Bendixen A. Electrophysiological correlates of speaker segregation and foreground-background selection in ambiguous listening situations. Neuroscience. PMID 28735101 DOI: 10.1016/J.Neuroscience.2017.07.021  0.764
2017 Bader M, Schröger E, Grimm S. How regularity representations of short sound patterns that are based on relative or absolute pitch information establish over time: An EEG study. Plos One. 12: e0176981. PMID 28472146 DOI: 10.1371/Journal.Pone.0176981  0.816
2016 Volosin M, Grimm S, Horváth J. Exploiting temporal predictability: Event-related potential correlates of task-supportive temporal cue processing in auditory distraction. Brain Research. 1639: 120-31. PMID 26947619 DOI: 10.1016/J.Brainres.2016.02.044  0.696
2016 Aghamolaei M, Zarnowiec K, Grimm S, Escera C. Functional dissociation between regularity encoding and deviance detection along the auditory hierarchy. The European Journal of Neuroscience. 43: 529-35. PMID 26613542 DOI: 10.1111/Ejn.13138  0.577
2015 Grimm S, Escera C, Nelken I. Early indices of deviance detection in humans and animal models. Biological Psychology. PMID 26656286 DOI: 10.1016/J.Biopsycho.2015.11.017  0.509
2015 Althen H, Huotilainen M, Grimm S, Escera C. Middle latency response correlates of single and double deviant stimuli in a multi-feature paradigm. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 127: 388-396. PMID 25980983 DOI: 10.1016/J.Clinph.2015.04.058  0.387
2015 Cornella M, Bendixen A, Grimm S, Leung S, Schröger E, Escera C. Spatial auditory regularity encoding and prediction: human middle-latency and long-latency auditory evoked potentials. Brain Research. PMID 25912975 DOI: 10.1016/J.Brainres.2015.04.018  0.83
2015 Cacciaglia R, Escera C, Slabu L, Grimm S, Sanjuán A, Ventura-Campos N, Ávila C. Involvement of the human midbrain and thalamus in auditory deviance detection. Neuropsychologia. 68: 51-8. PMID 25556848 DOI: 10.1016/J.Neuropsychologia.2015.01.001  0.56
2015 Recasens M, Leung S, Grimm S, Nowak R, Escera C. Repetition suppression and repetition enhancement underlie auditory memory-trace formation in the human brain: an MEG study. Neuroimage. 108: 75-86. PMID 25528656 DOI: 10.1016/J.Neuroimage.2014.12.031  0.495
2014 Recasens M, Grimm S, Wollbrink A, Pantev C, Escera C. Encoding of nested levels of acoustic regularity in hierarchically organized areas of the human auditory cortex. Human Brain Mapping. 35: 5701-16. PMID 24996147 DOI: 10.1002/Hbm.22582  0.54
2014 Weise A, Grimm S, Trujillo-Barreto NJ, Schröger E. Timing matters: the processing of pitch relations. Frontiers in Human Neuroscience. 8: 387. PMID 24966823 DOI: 10.3389/Fnhum.2014.00387  0.789
2014 Escera C, Leung S, Grimm S. Deviance detection based on regularity encoding along the auditory hierarchy: electrophysiological evidence in humans. Brain Topography. 27: 527-38. PMID 24218032 DOI: 10.1007/S10548-013-0328-4  0.565
2014 Recasens M, Grimm S, Capilla A, Nowak R, Escera C. Two sequential processes of change detection in hierarchically ordered areas of the human auditory cortex. Cerebral Cortex (New York, N.Y. : 1991). 24: 143-53. PMID 23042732 DOI: 10.1093/Cercor/Bhs295  0.547
2013 Cornella M, Leung S, Grimm S, Escera C. Regularity encoding and deviance detection of frequency modulated sweeps: human middle- and long-latency auditory evoked potentials. Psychophysiology. 50: 1275-81. PMID 24016075 DOI: 10.1111/Psyp.12137  0.517
2013 Althen H, Grimm S, Escera C. Simple and complex acoustic regularities are encoded at different levels of the auditory hierarchy. The European Journal of Neuroscience. 38: 3448-55. PMID 23992232 DOI: 10.1111/Ejn.12346  0.552
2013 Leung S, Recasens M, Grimm S, Escera C. Electrophysiological index of acoustic temporal regularity violation in the middle latency range. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 124: 2397-405. PMID 23830004 DOI: 10.1016/J.Clinph.2013.06.001  0.556
2012 Cornella M, Leung S, Grimm S, Escera C. Detection of simple and pattern regularity violations occurs at different levels of the auditory hierarchy. Plos One. 7: e43604. PMID 22916282 DOI: 10.1371/Journal.Pone.0043604  0.585
2012 Alho K, Grimm S, Mateo-León S, Costa-Faidella J, Escera C. Early processing of pitch in the human auditory system. The European Journal of Neuroscience. 36: 2972-8. PMID 22765015 DOI: 10.1111/J.1460-9568.2012.08219.X  0.54
2012 Leung S, Cornella M, Grimm S, Escera C. Is fast auditory change detection feature specific? An electrophysiological study in humans. Psychophysiology. 49: 933-42. PMID 22591493 DOI: 10.1111/J.1469-8986.2012.01375.X  0.539
2012 Tavano A, Grimm S, Costa-Faidella J, Slabu L, Schröger E, Escera C. Spectrotemporal processing drives fast access to memory traces for spoken words. Neuroimage. 60: 2300-8. PMID 22387169 DOI: 10.1016/J.Neuroimage.2012.02.041  0.715
2012 Slabu L, Grimm S, Escera C. Novelty detection in the human auditory brainstem. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 1447-52. PMID 22279229 DOI: 10.1523/Jneurosci.2557-11.2012  0.577
2012 Grimm S, Recasens M, Althen H, Escera C. Ultrafast tracking of sound location changes as revealed by human auditory evoked potentials. Biological Psychology. 89: 232-9. PMID 22037091 DOI: 10.1016/J.Biopsycho.2011.10.014  0.576
2012 Grimm S, Escera C. Auditory deviance detection revisited: evidence for a hierarchical novelty system. International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology. 85: 88-92. PMID 21669238 DOI: 10.1016/J.Ijpsycho.2011.05.012  0.597
2011 Costa-Faidella J, Baldeweg T, Grimm S, Escera C. Interactions between "what" and "when" in the auditory system: temporal predictability enhances repetition suppression. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 18590-7. PMID 22171057 DOI: 10.1523/Jneurosci.2599-11.2011  0.594
2011 Althen H, Grimm S, Escera C. Fast detection of unexpected sound intensity decrements as revealed by human evoked potentials. Plos One. 6: e28522. PMID 22163029 DOI: 10.1371/Journal.Pone.0028522  0.597
2011 Timm J, Weise A, Grimm S, Schröger E. An Asymmetry in the Automatic Detection of the Presence or Absence of a Frequency Modulation within a Tone: A Mismatch Negativity Study. Frontiers in Psychology. 2: 189. PMID 21852979 DOI: 10.3389/Fpsyg.2011.00189  0.782
2011 Costa-Faidella J, Grimm S, Slabu L, Díaz-Santaella F, Escera C. Multiple time scales of adaptation in the auditory system as revealed by human evoked potentials. Psychophysiology. 48: 774-83. PMID 20946129 DOI: 10.1111/J.1469-8986.2010.01144.X  0.527
2011 Grimm S, Escera C, Slabu L, Costa-Faidella J. Electrophysiological evidence for the hierarchical organization of auditory change detection in the human brain. Psychophysiology. 48: 377-84. PMID 20636288 DOI: 10.1111/J.1469-8986.2010.01073.X  0.512
2010 Slabu L, Escera C, Grimm S, Costa-Faidella J. Early change detection in humans as revealed by auditory brainstem and middle-latency evoked potentials. The European Journal of Neuroscience. 32: 859-65. PMID 20626459 DOI: 10.1111/J.1460-9568.2010.07324.X  0.57
2010 Bendixen A, Grimm S, Deouell LY, Wetzel N, Mädebach A, Schröger E. The time-course of auditory and visual distraction effects in a new crossmodal paradigm. Neuropsychologia. 48: 2130-9. PMID 20385149 DOI: 10.1016/J.Neuropsychologia.2010.04.004  0.737
2010 Weise A, Grimm S, Müller D, Schröger E. A temporal constraint for automatic deviance detection and object formation: A mismatch negativity study. Brain Research. 1331: 88-95. PMID 20307508 DOI: 10.1016/J.Brainres.2010.03.049  0.576
2010 Grimm S, Bendixen A, Deouell LY, Wetzel N, Mädebach A, Schröger E. Asymmetries in the time course of distraction elicited by changes in the auditory and visual modalities International Journal of Psychophysiology. 77: 231-231. DOI: 10.1016/J.Ijpsycho.2010.06.334  0.808
2010 Costa-Faidella J, Grimm S, Slabu L, Díaz-Santaella F, Escera C. Modelling the auditory scene: Adaptation in multiple time scales and the role of contextual rhythm International Journal of Psychophysiology. 77: 221-221. DOI: 10.1016/J.Ijpsycho.2010.06.311  0.403
2010 Grimm S, Escera C, Costa-Faidella J, Slabu L. The time-course of processing auditory frequency and location deviants as reflected by middle- and long-latency auditory evoked potentials International Journal of Psychophysiology. 77: 338-338. DOI: 10.1016/J.Ijpsycho.2010.06.278  0.522
2009 Grimm S, Bendixen A, Deouell LY, Schröger E. Distraction in a visual multi-deviant paradigm: behavioral and event-related potential effects. International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology. 72: 260-6. PMID 19452601 DOI: 10.1016/J.Ijpsycho.2009.01.005  0.716
2008 Grimm S, Schröger E, Bendixen A, Bäss P, Roye A, Deouell LY. Optimizing the auditory distraction paradigm: behavioral and event-related potential effects in a lateralized multi-deviant approach. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 119: 934-47. PMID 18289933 DOI: 10.1016/J.Clinph.2007.12.011  0.806
2007 Grimm S, Schröger E. The processing of frequency deviations within sounds: evidence for the predictive nature of the Mismatch Negativity (MMN) system. Restorative Neurology and Neuroscience. 25: 241-9. PMID 17943002  0.369
2007 Weise A, Müller D, Grimm S, Rübsamen R, Schröger E. Differential processing of terminal tone parts within structured and non-structured tones. Neuroscience Letters. 421: 163-7. PMID 17570584 DOI: 10.1016/J.Neulet.2007.05.029  0.547
2007 Röttger S, Schröger E, Grube M, Grimm S, Rübsamen R. Mismatch negativity on the cone of confusion. Neuroscience Letters. 414: 178-82. PMID 17223265 DOI: 10.1016/J.Neulet.2006.12.023  0.536
2006 Grimm S, Roeber U, Trujillo-Barreto NJ, Schröger E. Mechanisms for detecting auditory temporal and spectral deviations operate over similar time windows but are divided differently between the two hemispheres. Neuroimage. 32: 275-82. PMID 16651011 DOI: 10.1016/J.Neuroimage.2006.03.032  0.806
2006 Bendixen A, Grimm S, Schröger E. The relation between onset, offset, and duration perception as examined by psychophysical data and event-related brain potentials Journal of Psychophysiology. 20: 40-51. DOI: 10.1027/0269-8803.20.1.40  0.825
2005 Grimm S, Schröger E. Pre-attentive and attentive processing of temporal and frequency characteristics within long sounds. Brain Research. Cognitive Brain Research. 25: 711-21. PMID 16253485 DOI: 10.1016/J.Cogbrainres.2005.09.003  0.522
2005 Bendixen A, Grimm S, Schröger E. Human auditory event-related potentials predict duration judgments. Neuroscience Letters. 383: 284-8. PMID 15955422 DOI: 10.1016/J.Neulet.2005.04.034  0.737
2005 Senkowski D, Röttger S, Grimm S, Foxe JJ, Herrmann CS. Kanizsa subjective figures capture visual spatial attention: evidence from electrophysiological and behavioral data. Neuropsychologia. 43: 872-86. PMID 15716159 DOI: 10.1016/J.Neuropsychologia.2004.09.010  0.416
2004 Grimm S, Widmann A, Schröger E. Differential processing of duration changes within short and long sounds in humans. Neuroscience Letters. 356: 83-6. PMID 14746869 DOI: 10.1016/J.Neulet.2003.11.035  0.727
Low-probability matches (unlikely to be authored by this person)
2014 Escera C, Aghamollaie M, Althen H, Shiga T, Zarnowiec K, Grimm S. Functional relationships between mismatch negativity and early deviance-related effects International Journal of Psychophysiology. 94: 146. DOI: 10.1016/J.Ijpsycho.2014.08.662  0.267
2018 Grimm SE, Armstrong N, Ramaekers BLT, Pouwels X, Lang S, Petersohn S, Riemsma R, Worthy G, Stirk L, Ross J, Kleijnen J, Joore MA. Nivolumab for Treating Metastatic or Unresectable Urothelial Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics. PMID 30293207 DOI: 10.1007/s40273-018-0723-5  0.138
2018 Ramaekers BLT, Riemsma R, Grimm S, Fayter D, Deshpande S, Armstrong N, Witlox W, Pouwels X, Duffy S, Worthy G, Kleijnen J, Joore MA. Arsenic Trioxide for Treating Acute Promyelocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics. PMID 30426463 DOI: 10.1007/s40273-018-0738-y  0.131
2021 Grimm SE, Witlox W, Wolff R, Chalker A, Hiligsmann M, Wijnen B, Ahmadu C, Ryder S, Armstrong N, Duffy S, Syndikus I, Kleijnen J, Joore MA. Mogamulizumab for Previously Treated Mycosis Fungoides and Sézary Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics. PMID 34664200 DOI: 10.1007/s40273-021-01098-3  0.124
2022 Otten T, Riemsma R, Wijnen B, Armstrong N, Stirk L, Gordon C, Ramaekers B, Kleijnen J, Joore M, Grimm S. Belimumab for Treating Active Autoantibody-Positive Systemic Lupus Erythematosus: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics. 40: 851-861. PMID 35802295 DOI: 10.1007/s40273-022-01166-2  0.123
2024 Westwood M, Ramaekers B, Grimm S, Armstrong N, Wijnen B, Ahmadu C, de Kock S, Noake C, Joore M. Software with artificial intelligence-derived algorithms for analysing CT brain scans in people with a suspected acute stroke: a systematic review and cost-effectiveness analysis. Health Technology Assessment (Winchester, England). 28: 1-204. PMID 38512017 DOI: 10.3310/RDPA1487  0.12
2021 Grimm SE, Wijnen B, Riemsma R, Fayter D, Armstrong N, Ahmadu C, Brandts L, Misso K, Kirwan JR, Kleijnen J, Joore MA. Filgotinib for Moderate to Severe Rheumatoid Arthritis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics. PMID 34448148 DOI: 10.1007/s40273-021-01080-z  0.117
2023 van Asselt ADI, Armstrong N, Kimman M, Peeters A, McDermott K, Stirk L, Ahmadu C, Govers TM, Hoentjen F, Joore MA, Grimm SE. Filgotinib for Treating Moderately to Severely Active Ulcerative Colitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics. PMID 36725788 DOI: 10.1007/s40273-023-01244-z  0.113
2017 Tappenden P, Carroll C, Stevens JW, Rawdin A, Grimm S, Clowes M, Kaltenthaler E, Ingram JR, Collier F, Ghazavi M. Adalimumab for Treating Moderate-to-Severe Hidradenitis Suppurativa: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics. PMID 28176188 DOI: 10.1007/s40273-017-0488-2  0.111
2019 Grimm SE, Fayter D, Ramaekers BLT, Petersohn S, Riemsma R, Armstrong N, Pouwels X, Witlox W, Noake C, Worthy G, Kleijnen J, Joore MA. Pembrolizumab for Treating Relapsed or Refractory Classical Hodgkin Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics. 37: 1195-1207. PMID 30895564 DOI: 10.1007/s40273-019-00792-7  0.109
2023 Witlox W, Grimm S, Howick J, Armstrong N, Ahmadu C, McDermott K, Otten T, Noake C, Wolff R, Joore M. Oral Azacitidine for Maintenance Treatment of Acute Myeloid Leukaemia After Induction Therapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics. PMID 37129774 DOI: 10.1007/s40273-023-01272-9  0.109
2020 Witlox WJA, van Asselt ADI, Wolff R, Armstrong N, Worthy G, Chalker A, Buksnys T, Stirk L, Kleijnen J, Joore MA, Grimm SE. Durvalumab for the Treatment of Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics. 38: 317-324. PMID 31814080 DOI: 10.1007/s40273-019-00870-w  0.103
2020 Wijnen B, Armstrong N, Ramaekers B, Witlox W, Westwood M, Fayter D, Ryder S, Buksnys T, Worthy G, Misso K, Grimm S, Kleijnen J, Joore M. Cannabidiol for Adjuvant Treatment of Seizures Associated with Lennox-Gastaut Syndrome and Dravet Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics. 38: 1043-1053. PMID 32514751 DOI: 10.1007/s40273-020-00932-4  0.097
2021 Grimm SE, Pouwels X, Ramaekers BLT, Wijnen B, Knies S, Grutters J, Joore MA. Correction to: Building a trusted framework for uncertainty assessment in rare diseases: suggestions for improvement (Response to "TRUST4RD: tool for reducing uncertainties in the evidence generation for specialised treatments for rare diseases"). Orphanet Journal of Rare Diseases. 16: 320. PMID 34281581 DOI: 10.1186/s13023-021-01938-7  0.095
2023 Kunst N, Siu A, Drummond M, Grimm S, Grutters J, Husereau D, Koffijberg H, Rothery C, Wilson EC, Heath A. CHEERS Value of Information (CHEERS-VOI) Reporting Standards - Explanation and Elaboration. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. PMID 37414276 DOI: 10.1016/j.jval.2023.06.014  0.09
2018 Lang S, Armstrong N, Deshpande S, Ramaekers B, Grimm S, de Kock S, Kleijnen J, Westwood ME. ANNALS EXPRESS: Clinically inappropriate post-hoc exclusion of study participants from test accuracy calculations: The ROMA score, an example from a recent NICE diagnostic assessment. Annals of Clinical Biochemistry. 4563218782722. PMID 29848041 DOI: 10.1177/0004563218782722  0.09
2021 Grimm SE, Pouwels X, Ramaekers BLT, van Ravesteyn NT, Sankatsing VDV, Grutters J, Joore MA. Implementation Barriers to Value of Information Analysis in Health Technology Decision Making: Results From a Process Evaluation. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 24: 1126-1136. PMID 34372978 DOI: 10.1016/j.jval.2021.03.013  0.081
2023 Kunst N, Siu A, Drummond M, Grimm S, Grutters J, Husereau D, Koffijberg H, Rothery C, Wilson ECF, Heath A. Reporting Economic Evaluations with Value of Information Analyses Using the CHEERS Value of Information (CHEERS-VOI) Reporting Guideline. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 272989X231214791. PMID 38097383 DOI: 10.1177/0272989X231214791  0.074
2021 Grimm SE, Pouwels X, Ramaekers BLT, Wijnen B, Knies S, Grutters J, Joore MA. Building a trusted framework for uncertainty assessment in rare diseases: suggestions for improvement (Response to "TRUST4RD: tool for reducing uncertainties in the evidence generation for specialised treatments for rare diseases"). Orphanet Journal of Rare Diseases. 16: 62. PMID 33522936 DOI: 10.1186/s13023-020-01666-4  0.074
2022 Grimm SE, Witlox W, Wolff R, Chalker A, Hiligsmann M, Wijnen B, Ahmadu C, Ryder S, Armstrong N, Duffy S, Syndikus I, Kleijnen J, Joore MA. Correction to: Mogamulizumab for Previously Treated Mycosis Fungoides and Sézary Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics. PMID 35364758 DOI: 10.1007/s40273-022-01144-8  0.066
2023 Otten TM, Grimm SE, Ramaekers B, Joore MA. Comprehensive Review of Methods to Assess Uncertainty in Health Economic Evaluations. Pharmacoeconomics. PMID 36943674 DOI: 10.1007/s40273-023-01242-1  0.066
2017 Grimm SE, Strong M, Brennan A, Wailoo AJ. The HTA Risk Analysis Chart: Visualising the Need for and Potential Value of Managed Entry Agreements in Health Technology Assessment. Pharmacoeconomics. PMID 28849538 DOI: 10.1007/s40273-017-0562-9  0.064
2021 Westwood ME, Armstrong N, Worthy G, Fayter D, Ramaekers BLT, Grimm S, Buksnys T, Ross J, Mills NL, Body R, Collinson PO, Timmis A, Kleijnen J. Optimizing the Use of High-Sensitivity Troponin Assays for the Early Rule-out of Myocardial Infarction in Patients Presenting with Chest Pain: A Systematic Review. Clinical Chemistry. 67: 237-244. PMID 33418577 DOI: 10.1093/clinchem/hvaa280  0.063
2023 Otten T, Riemsma R, Wijnen B, Armstrong N, Stirk L, Gordon C, Ramaekers B, Kleijnen J, Joore M, Grimm S. Correction: Belimumab for Treating Active Autoantibody‑Positive Systemic Lupus Erythematosus: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics. 41: 1551. PMID 37665503 DOI: 10.1007/s40273-023-01315-1  0.059
2016 Grimm SE, Dixon S, Stevens JW. When Future Change Matters: Modeling Future Price and Diffusion in Health Technology Assessments of Medical Devices. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 19: 720-726. PMID 27712696 DOI: 10.1016/j.jval.2016.06.002  0.058
2020 de Wit M, Guillemin F, Grimm S, Boonen A, Fautrel B, Joore M. Patient engagement in health technology assessment (HTA) and the regulatory process: what about rheumatology? Rmd Open. 6. PMID 33148783 DOI: 10.1136/rmdopen-2020-001286  0.055
2017 Grimm SE, Dixon S, Stevens JW. Assessing the Expected Value of Research Studies in Reducing Uncertainty and Improving Implementation Dynamics. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 272989X16686766. PMID 28061042 DOI: 10.1177/0272989X16686766  0.055
2020 Witlox WJA, Grimm SE, Riemsma R, Armstrong N, Ryder S, Duffy S, Carrera VH, Posadzki P, Worthy G, Pouwels XGLV, Ramaekers BLT, Kleijnen J, Joore MA, van Asselt ADI. Lenalidomide with Rituximab for Previously Treated Follicular Lymphoma and Marginal Zone Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics. PMID 33145711 DOI: 10.1007/s40273-020-00971-x  0.055
2023 Grimm SE, Pouwels XGLV, Ramaekers BLT, Wijnen B, Grutters J, Joore MA. Response to "UNCERTAINTY MANAGEMENT IN REGULATORY AND HEALTH TECHNOLOGY ASSESSMENT DECISION-MAKING ON DRUGS: GUIDANCE OF THE HTAi-DIA WORKING GROUP". International Journal of Technology Assessment in Health Care. 39: e70. PMID 37822085 DOI: 10.1017/S026646232300260X  0.053
2021 Westwood M, Ramaekers B, Grimm S, Worthy G, Fayter D, Armstrong N, Buksnys T, Ross J, Joore M, Kleijnen J. High-sensitivity troponin assays for early rule-out of acute myocardial infarction in people with acute chest pain: a systematic review and economic evaluation. Health Technology Assessment (Winchester, England). 25: 1-276. PMID 34061019 DOI: 10.3310/hta25330  0.047
2021 Petersohn S, Grimm SE, Ramaekers BLT, Ten Cate-Hoek AJ, Joore MA. Exploring the Feasibility of Comprehensive Uncertainty Assessment in Health Economic Modeling: A Case Study. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 24: 983-994. PMID 34243842 DOI: 10.1016/j.jval.2021.01.004  0.047
2020 Grimm SE, Pouwels X, Ramaekers BLT, Wijnen B, Knies S, Grutters J, Joore MA. Development and Validation of the TRansparent Uncertainty ASsessmenT (TRUST) Tool for Assessing Uncertainties in Health Economic Decision Models. Pharmacoeconomics. 38: 205-216. PMID 31709496 DOI: 10.1007/s40273-019-00855-9  0.044
2020 Sankatsing VDV, Juraniec K, Grimm SE, Joore MA, Pijnappel RM, de Koning HJ, van Ravesteyn NT. Cost-effectiveness of Digital Breast Tomosynthesis in Population-based Breast Cancer Screening: A Probabilistic Sensitivity Analysis. Radiology. 297: 40-48. PMID 32749212 DOI: 10.1148/radiol.2020192505  0.041
2018 Grimm SE, Stevens JW, Dixon S. Estimating Future Health Technology Diffusion Using Expert Beliefs Calibrated to an Established Diffusion Model. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 21: 944-950. PMID 30098672 DOI: 10.1016/j.jval.2018.01.010  0.041
2020 Fautrel B, Boonen A, de Wit M, Grimm S, Joore M, Guillemin F. Cost assessment of health interventions and diseases. Rmd Open. 6. PMID 33148784 DOI: 10.1136/rmdopen-2020-001287  0.039
2018 Dickson R, Boland A, Duarte R, Kotas E, Woolacott N, Hodgson R, Riemsma R, Grimm S, Ramaekers B, Joore M, Büyükkaramikli N, Kaltenthaler E, Stevenson M, Pandor A, Edwards S, et al. EMA and NICE Appraisal Processes for Cancer Drugs: Current Status and Uncertainties. Applied Health Economics and Health Policy. PMID 29808296 DOI: 10.1007/s40258-018-0393-7  0.039
2023 Kunst N, Siu A, Drummond M, Grimm S, Grutters J, Husereau D, Koffijberg H, Rothery C, Wilson ECF, Heath A. Comment on: "Adding Value to CHEERS: New Reporting Standards for Value of Information Analyses". Applied Health Economics and Health Policy. PMID 38141116 DOI: 10.1007/s40258-023-00856-y  0.038
2021 Grimm SE, Pouwels X, Ramaekers BLT, Wijnen B, Otten T, Grutters J, Joore MA. State of the ART? Two New Tools for Risk Communication in Health Technology Assessments. Pharmacoeconomics. PMID 34278550 DOI: 10.1007/s40273-021-01060-3  0.036
2020 Guillemin F, de Wit M, Fautrel B, Grimm S, Joore M, Boonen A. Steps in implementing a health economic evaluation. Rmd Open. 6. PMID 33148785 DOI: 10.1136/rmdopen-2020-001288  0.033
2020 Joore M, Grimm S, Boonen A, de Wit M, Guillemin F, Fautrel B. Health technology assessment: a framework. Rmd Open. 6. PMID 33148786 DOI: 10.1136/rmdopen-2020-001289  0.03
2023 Handels R, Grimm S, Blokland A, Possemis N, Ramakers I, Sambeth A, Verhey F, Vos S, Joore M, Prickaerts J, Jönsson L. The value of maintaining cognition in patients with mild cognitive impairment: The innovation headroom and potential cost-effectiveness of roflumilast. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 36808801 DOI: 10.1002/alz.13001  0.03
2018 Westwood M, Ramaekers B, Lang S, Grimm S, Deshpande S, de Kock S, Armstrong N, Joore M, Kleijnen J. Risk scores to guide referral decisions for people with suspected ovarian cancer in secondary care: a systematic review and cost-effectiveness analysis. Health Technology Assessment (Winchester, England). 22: 1-264. PMID 30165935 DOI: 10.3310/hta22440  0.029
2023 Webers C, Grimm S, van Tubergen A, van Gaalen F, van der Heijde D, Joore M, Boonen A. The value of correctly diagnosing axial spondyloarthritis for patients and society. Seminars in Arthritis and Rheumatism. 62: 152242. PMID 37451047 DOI: 10.1016/j.semarthrit.2023.152242  0.018
2018 Hernandez Alava M, Wailoo A, Grimm S, Pudney S, Gomes M, Sadique Z, Meads D, O'Dwyer J, Barton G, Irvine L. EQ-5D-5L versus EQ-5D-3L: The Impact on Cost Effectiveness in the United Kingdom. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 21: 49-56. PMID 29304940 DOI: 10.1016/j.jval.2017.09.004  0.012
Hide low-probability matches.